Skip to content
    This content is from our sponsor. The sponsor has sole editorial control.

    The Dexcom G5® Mobile Continuous Glucose Monitoring (CGM) System is the first FDA-approved CGM that lets you make treatment decisions without pricking your finger.* It provides real-time glucose readings for patients with type 1 or type 2 diabetes every five minutes. With the Dexcom G5 Mobile, dynamic glucose data can be accessed and shared safely with up to 5 followers† anywhere, anytime to your smart device.‡ The Dexcom G5 Mobile is a CGM system approved for adults and pediatric patients two years of age and older.§

    Fill out this form to see if Dexcom is right for you:


    WebMD and Dexcom respect your privacy choices. By completing the form below you will transfer your information to Dexcom and its designated parties in order to fulfill your request. Dexcom and its designated parties will use your information as outlined in the Dexcom Privacy Policy. Entry of the below information indicates your agreement with the Dexcom Terms of Use.

    *CGM-based treatment requires fingersticks for calibration, if patient is taking acetaminophen, or if symptoms/expectations do not match CGM readings, and if not performed, may result in hypoglycemia. Important risk info.

    †Separate Follow app required

    ‡For a list of compatible devices, visit

    §Dexcom G5 Mobile user guide, 2017.